FINHUB Insights

Kenvue Q4 FY25: where the revenue came from and where it went

The whole income statement of Kenvue for this quarter, as one diagram: what earned the revenue, and what it went on.

Period
Sep 29 – Dec 28, 2025
Reported
Feb 20, 2026 10-K accession 0001944048-26-000030

Revenue$3.78B +3% year over year
Gross profit$2.14B 57% margin
Operating profit$0.54B 14% margin
Net profit$0.33B 9% margin
100% free

It's free. All of it.

A free account opens every diagram. We send one link to confirm your address, and that is the whole of it.

Already have an account? Sign in

The numbers

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 28, 2025).
ItemValueShare of revenueYear over year
Revenue 3.78 100% +3%
Self care 1.59 42% +1%
Essential health 1.15 30% +6%
Skin health & beauty 1.04 28% +3%
Cost of revenue−1.6443%
Gross profit2.1457% margin+0pp
R&D−0.102%+0pp
SG&A−1.5040%−1pp
Operating profit0.5414% margin+1pp
Interest & other costs−0.11
Tax−0.10
Net profit0.33 9% margin+1pp

Source of the numbers: structured XBRL data from the filing (10-K). The diagram is generated automatically and checked against EDGAR before release. The fourth quarter has no column of its own in an annual report, so it is the full year minus the first nine months. How we calculate it → About and methodology.

99 of 418 companies, most recently reported first